ArticleFrontiers in medicine2026
An exploratory study evaluating the predictive capacity of the CALLY index and SOFA-2 for 28-day all-cause mortality in patients with septic shock.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early risk stratification of septic shock remains challenging. Although the SOFA score is widely used, its prognostic accuracy is limited in contemporary ICU practice. The C-reactive protein-albumin-lymphocyte (CALLY) index reflects inflammation, nutritional reserve, and immune status, but its independent and incremental prognostic value beyond organ dysfunction scores remains uncertain. Methods: In this retrospective cohort study, 204 patients with septic shock were enrolled and stratified according to 28-day mortality. Baseline clinical characteristics, laboratory parameters, and severity scores were collected. The prognostic value of CALLY, SOFA, and SOFA-2 was evaluated using univariable and multivariable logistic regression analyses. Discriminative ability was assessed using receiver operating characteristic (ROC) curves, and pairwise AUC comparisons were planned using the DeLong test. In addition, subgroup analyses were performed to explore the stability of associations between CALLY and mortality across predefined clinical subgroups. Results: Among 204 patients, 104 (51.0%) died within 28 days. Non-survivors presented with older age, higher lactate levels, increased inflammatory markers, worse organ dysfunction, and higher severity scores. In multivariable analysis, SOFA-2 remained independently associated with 28-day mortality (adjusted OR 1.26, 95% CI 1.08-1.50; Conclusion: SOFA-2 showed numerically better prognostic performance than conventional SOFA for 28-day mortality in patients with septic shock. Although CALLY was associated with outcomes in descriptive and subgroup analyses, it was not an independent predictor and did not provide a clinically meaningful incremental improvement when added to SOFA-2 in this cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.